Variant report
Variant | nsv983728 |
---|---|
Chromosome Location | chr13:85055175-85063727 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531643402 | chr13:85055187-85055188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376572377 | chr13:85055218-85055219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576541595 | chr13:85055281-85055282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571153751 | chr13:85055289-85055290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533727577 | chr13:85055292-85055293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575760176 | chr13:85055355-85055356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112747927 | chr13:85055378-85055379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7994870 | chr13:85055407-85055408 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs181101388 | chr13:85055516-85055517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575907700 | chr13:85055539-85055540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9319046 | chr13:85055565-85055566 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs558488112 | chr13:85055574-85055575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17312796 | chr13:85055615-85055616 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560230589 | chr13:85055621-85055622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540101454 | chr13:85055642-85055643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559289204 | chr13:85055689-85055690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540806196 | chr13:85055733-85055734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141055081 | chr13:85055769-85055770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143119202 | chr13:85055862-85055863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs148228534 | chr13:85055864-85055865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533145266 | chr13:85055878-85055879 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562901666 | chr13:85055893-85055894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531602579 | chr13:85055897-85055898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9575588 | chr13:85055918-85055919 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs200986522 | chr13:85055931-85055932 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112423412 | chr13:85055935-85055936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs67298039 | chr13:85055936-85055937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10680943 | chr13:85055938-85055939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571190370 | chr13:85055988-85055989 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150302802 | chr13:85056009-85056010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547212708 | chr13:85056032-85056033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563223262 | chr13:85056048-85056049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371976525 | chr13:85056083-85056084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567317184 | chr13:85056121-85056122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562432367 | chr13:85056122-85056123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536359626 | chr13:85056168-85056169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76260881 | chr13:85056203-85056204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17078212 | chr13:85056208-85056209 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs112999626 | chr13:85056222-85056223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186942078 | chr13:85056243-85056244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191840837 | chr13:85056292-85056293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs36023075 | chr13:85056305-85056306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540893911 | chr13:85056328-85056329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143325030 | chr13:85056333-85056334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112013342 | chr13:85056359-85056360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543151133 | chr13:85056360-85056361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562828866 | chr13:85056453-85056454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138539234 | chr13:85056482-85056483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544978020 | chr13:85056502-85056503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564909161 | chr13:85056521-85056522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85045200-85055200 | Weak transcription | Aorta | Aorta |
2 | chr13:85054000-85056000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr13:85054200-85055800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr13:85054800-85055400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr13:85055400-85055800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr13:85055600-85056600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr13:85055800-85056400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr13:85055800-85056600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr13:85056000-85056600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr13:85056200-85056400 | Enhancers | HMEC | breast |
11 | chr13:85056200-85056400 | Enhancers | NHEK | skin |